Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comis

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Hybridoma|July 1, 1986
Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinomaL M Weiner, Z Steplewski, H Koprowski, et al.
Medical and Pediatric Oncology|January 1, 1978
The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomasS T Crooke, L H Einhorn, R L Comis, et al.
Journal of Clinical Pharmacology|March 1, 1991
Pharmacologic study of etoposide and cisplatin by the intraperitoneal routeP J O'Dwyer, F LaCreta, M Hogan, et al.
Cancer Treatment Reports|December 1, 1978
Phase I and preliminary phase II study of neocarzinostatinT W Griffin, R L Comis, J J Lokich, et al.
Investigational New Drugs|July 1, 1992
Phase II study of amonafide in advanced and recurrent sarcoma patientsR P Perez, S L Nash, R F Ozols, et al.
Journal of Biological Response Modifiers|August 1, 1989
Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 studyR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancerP J O'Dwyer, A R Paul, J Walczak, et al.
Cancer Investigation|January 1, 1995
Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinomaC J Langer, R Catalano, L M Weiner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracilG R Hudes, F LaCreta, R J DeLap, et al.
Cancer Research|June 15, 1991
Pharmacokinetic study of trimetrexate in combination with cisplatinG R Hudes, F LaCreta, J Walczak, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Hybridoma|July 1, 1986
Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinomaL M Weiner, Z Steplewski, H Koprowski, et al.
Medical and Pediatric Oncology|January 1, 1978
The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomasS T Crooke, L H Einhorn, R L Comis, et al.
Journal of Clinical Pharmacology|March 1, 1991
Pharmacologic study of etoposide and cisplatin by the intraperitoneal routeP J O'Dwyer, F LaCreta, M Hogan, et al.
Cancer Treatment Reports|December 1, 1978
Phase I and preliminary phase II study of neocarzinostatinT W Griffin, R L Comis, J J Lokich, et al.
Investigational New Drugs|July 1, 1992
Phase II study of amonafide in advanced and recurrent sarcoma patientsR P Perez, S L Nash, R F Ozols, et al.
Journal of Biological Response Modifiers|August 1, 1989
Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 studyR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancerP J O'Dwyer, A R Paul, J Walczak, et al.
Cancer Investigation|January 1, 1995
Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinomaC J Langer, R Catalano, L M Weiner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracilG R Hudes, F LaCreta, R J DeLap, et al.
Cancer Research|June 15, 1991
Pharmacokinetic study of trimetrexate in combination with cisplatinG R Hudes, F LaCreta, J Walczak, et al.
Pageof 12